Tooley, J. E., Vudattu, N., Choi, J., Cotsapas, C., Devine, L., Raddassi, K., . . . Herold, K. C. (2015). Changes in T cell subsets identify responders to FcR non-binding anti-CD3 mAb (teplizumab) in patients with Type 1 diabetes. Eur J Immunol.
Chicago Style citaatTooley, James E., et al. "Changes in T Cell Subsets Identify Responders to FcR Non-binding Anti-CD3 MAb (teplizumab) in Patients With Type 1 Diabetes." Eur J Immunol 2015.
MLA citatieTooley, James E., et al. "Changes in T Cell Subsets Identify Responders to FcR Non-binding Anti-CD3 MAb (teplizumab) in Patients With Type 1 Diabetes." Eur J Immunol 2015.
Let op: Deze citaties zijn niet altijd 100% accuraat.